The International Journal of Biomedical Research and Healthcare Innovations (IJBRHI) (P-ISSN: XXXX-XXXX | E-ISSN: XXXX-XXXX) is an international scholarly journal dedicated to advancing scientific knowledge and promoting research developments in biomedical sciences, clinical medicine, healthcare technologies, and interdisciplinary health research.
The journal provides an academic platform for researchers, biomedical scientists, clinicians, healthcare professionals, and medical educators to communicate scientific findings, examine emerging healthcare challenges, and contribute to evidence-based medical knowledge.
The journal encompasses a broad spectrum of biomedical disciplines, including molecular biology, medical biotechnology, clinical research, human genetics, immunology, pharmacology, diagnostic sciences, biomedical engineering, regenerative medicine, and translational research. Particular emphasis is placed on investigations that integrate fundamental biomedical discoveries with practical healthcare applications, improved diagnostic approaches, therapeutic developments, and patient-centered medical innovations.
The journal also recognizes the growing significance of healthcare innovation in addressing contemporary medical challenges. Research examining digital health technologies, artificial intelligence in healthcare, precision medicine, biomedical devices, telemedicine, and emerging diagnostic or therapeutic systems falls within its interdisciplinary interests when supported by appropriate scientific evidence and methodological evaluation.
IJBRHI welcomes original empirical investigations, systematic reviews, meta-analyses, clinical studies, and interdisciplinary healthcare contributions across key medical domains:
Genomics, gene expression profiling, molecular mechanisms of disease, biomarkers, cellular pathology, and functional genetic variation analysis.
Immunopathology, vaccine development, drug discovery, pharmacokinetics, therapeutic targeting, host-pathogen interactions, and drug resistance.
Tissue engineering, stem cell therapy, biomaterials, medical device development, bio-sensors, prosthetics, and bio-fabrication systems.
Translational studies, clinical trials, therapeutic protocols, patient outcomes, diagnostic validation, and evidence-based clinical practices.
Medical artificial intelligence, predictive clinical analytics, digital pathology, health informatics, telemedicine, and wearable health technologies.
Targeted therapies, individualized patient care, advanced diagnostic platforms, point-of-care testing, molecular imaging, and liquid biopsy assays.
Recombinant protein technology, viral vector design, biomanufacturing, clinical microbiology, infectious disease dynamics, and microbiome research.
Epidemiological studies, disease prevention, healthcare delivery models, patient safety, global health initiatives, and health technology assessment.
IJBRHI seeks to foster interdisciplinary biomedical collaboration and accelerate evidence-based healthcare innovations through focused objectives:
Modern health challenges require connecting fundamental biomedical mechanisms with real-world clinical delivery. By integrating basic scientific research with technological innovation, health professionals can improve diagnostic accuracy, treatment efficacy, and overall patient outcomes.
The journal prioritizes submissions that offer clear biological rationale, robust experimental or clinical design, transparent methodological reporting, and actionable scientific insights.
| Original Research Articles | Full-length empirical, basic scientific, laboratory-based, or translational studies presenting novel biomedical discoveries. |
| Clinical Investigations | Original observational, interventional, or diagnostic clinical research evaluating medical interventions and health outcomes. |
| Reviews & Meta-Analyses | Comprehensive narrative reviews, systematic reviews, and meta-analyses evaluating state-of-the-art medical therapies or basic science topics. |
| Methodological Studies | Papers describing, validating, or refining novel biomedical experimental techniques, diagnostic assays, or computational health models. |
| Short Communications | Concise reports presenting preliminary findings, novel technical diagnostic methods, or time-sensitive clinical observations. |
IJBRHI serves biomedical researchers, clinical specialists, medical biotechnologists, bioengineers, pharmacologists, epidemiologists, healthcare executives, and medical educators across research institutions, hospitals, and clinical trial centers globally.
Submitted manuscripts undergo rigorous desk screening for biomedical relevance, ethical compliance, plagiarism similarity, and structural alignment. Eligible papers proceed to double-blind peer review by qualified clinical and scientific experts.
Editorial decisions are guided strictly by scientific merit, clinical validity, and research integrity. Human subject studies must strictly document institutional ethics committee (IRB) approval and patient consent.
Publication Ethics: The journal's ethical framework is informed by COPE principles and ICMJE recommendations, prioritizing patient privacy, research integrity, and independent editorial evaluation.
Publication Frequency: The International Journal of Biomedical Research and Healthcare Innovations (IJBRHI) (P-ISSN: XXXX-XXXX | E-ISSN: XXXX-XXXX) is published on a quarterly schedule, releasing four issues per calendar year.